Kaczorowski et al. showed that oncolytic adenovirus-TRAIL-modified BM-MSCs can precisely migrate to tumor sites, but not in normal cells, inhibiting the growth of pancreatic cancer [147]. This evidence concerns the gene TNFSF10 and familial pancreatic carcinoma.